Russia's government to establish first domestic facility for heparin production

The Russian government, together with private investors, plans to invest up to $50 million to establish Russia’s first production of drugs for the treatment of blood clots, according to an official spokesman of the Russian Ministry of Health.

The project involves the setting up of production of heparin and low molecular weight heparin as well as drugs on their basis for the treatment of thromboembolic diseases.

It is planned that the new plant will be established in the city of Seversk in the Tomsk region. To date, the Russian government has started negotiations with some leading foreign drugmakers, regarding the possibility of the participation in the project, the names of which, however, are not disclosed. The new plant will create 250 new jobs.